Genmab, NHS England, Pistoia Alliance and Regeneron Win Bio-IT World Innovative Practices Awards

Organizations to be Featured During Friday Sessions of
Bio-IT World Conference & Expo, April 2-4 in Boston

BOSTON, March 21, 2025 /PRNewswire/ -- Bio-IT World has named Genmab, NHS (National Health Service) England, Pistoia Alliance, and Regeneron as the winners of its annual Innovative Practices Awards.

The organizations will be honored, beginning at 8:05 am, during the Friday Plenary Keynote session of the Bio-IT World Conference & Expo, where more than 2,800 biotech, pharmaceutical, healthcare, IT and investment leaders will gather in Boston from April 2-4. The winners will also discuss their innovations at 10:40 am Friday as part of the Data Management conference track.

The Bio-IT World Innovative Practices Awards recognize partnerships and projects pushing the bio-IT sector forward, promoting strategies that can be widely shared and implemented to improve the quality, pace, and reach of science and precision medicine. 

"In another year of tough competition, these four entries stood out as ones cleverly addressing real problems in the space," noted Allison Proffitt, Editorial Director, Bio-IT World. "They worked hard to understand the challenges facing teams and solve them strategically; prioritized patients' needs; and served as standard-bearers, quantifying how well we measure against our own most noble goals."  

Winners and excerpts from their project summaries include:

Knowledge Management Award: Genmab, nominated by Genedata, for "Accelerating chromatography workflows by redesigning and harmonizing data processing and reporting": 

"Genedata and Genmab developed Chromatics, a central, integrated software platform for analyzing and managing chromatography data …. The digitalized hardware-agnostic solution eliminates manual processes, automates and harmonizes data processing, provides well-annotated data for AI/ML initiatives, and effectively accelerates the development of biomolecules." 

Respect the Patient Award: NHS England, nominated by IQVIA, for "NHS Privacy Enhancing Technology":   

"Over the next decade, the UK National Health Service (NHS) is moving towards a data-enabled ecosystem with a connected, consistent data architecture. This will put patient data to work to optimize national insights and enable improved healthcare.

"The NHS-PET (Privacy Enhancing Technology) is a configurable platform powered by IQVIA Privacy Analytics which provides a secure, scalable solution for the auditing and privacy treatment of patient data within NHS Federated Data Platform (FDP). Benefits realized from PET include cutting waiting times and offering new virtual services." 

Lighthouse Award: Pistoia Alliance for "FAIR Maturity Matrix": 

"The Pistoia Alliance has achieved an industry first with the creation of its FAIR Maturity Matrix—an easy-to-use self-assessment tool that measures organizational leadership and technical maturity. Over 20 industry experts collaborated to create the tool, successfully simplifying and standardizing the many complex processes involved in FAIR data implementation.

"Ultimately, it will help the industry to unlock data siloes, successfully adopt emerging technologies to power data-led decisions, and work together to reduce the time and cost of bringing new therapies to market to meet unmet patient needs."

Informatics Award: Regeneron for "Unified Namespace for Preclinical Manufacturing and Process Development: an Industry 4.0 digitalization platform for real-time automated decision-making":

"Like others in the biotechnology space, [Regeneron Pharmaceuticals faces] the challenges of orchestrating the systems, applications, and integrations that power [their] laboratory instrumentation and plant equipment.

"Recently, their scientists and technologists partnered to address these challenges … and created a new platform: the Unified Name Space (UNS). The UNS seamlessly connects system integrations, automates interactions, and connects applications to make data available, irrespective of the source."

Ones to Watch
The judging panel also chose to highlight two entries with Honorable Mentions, including: 

Pistoia Alliance for "In Vitro Pharmacology (IVP)": 

"In vitro assays are crucial for assessing the safety and efficacy of active substances, metabolites, and impurities in Investigational New Drug (IND) and New Drug Application (NDA) submissions. However, inconsistent data standards for in vitro pharmacology (IVP) have hindered efficient in vitro testing and regulatory review. The Pistoia Alliance has addressed this issue through a public private partnership with regulators at the FDA, working collaboratively with biopharmaceutical industry stakeholders …. Efforts have standardized the way in which in vitro results are submitted using defined ontology and processes and using FAIR (Findable, Accessible, Interoperable, and Reusable) principles …."

Quris-AI for "BioAI—De-risking, Accelerating, and Personalizing Drug Development":

"Quris-AI's patented Bio-AI approach integrates AI, patient-on-chip biology, real-time sensing, and genetically diverse stem-cell-derived tissue. Its automated platform generates and collects data on millions of interactions between known drugs and organs on a chip, using this data to train its advanced AI platform. This technology solves the core clinical prediction challenge—predicting, before expensive clinical trials, which drug candidates will work safely and efficaciously in the human body."

Individuals interested in meeting these innovators at Bio-IT World 2025 can register here.

About Bio-IT World Conference & Expo
For over 20 years, Bio-IT World Conference & Expo has been the premier global event showcasing technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. By uniting a community of experts in life sciences, pharmaceuticals, clinical research, healthcare, informatics, and technology, the event pushes the boundaries of biomedical research, drug discovery and development, and patient outcomes. The program features inspiring plenary keynotes, 200+ educational and technical presentations, interactive panels, hands-on symposia, technical workshops, unparalleled networking opportunities, and an exhibit hall showcasing cutting-edge technologies and solutions. Attendees are invited to engage in transformative conversations on the latest advancements in digital and data transformations; AI; generative AI; machine learning (ML); real-world data strategies; pilot programs; new product results; and biotech investment trends.

SOURCE Bio-IT World Conference & Expo